Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-034013
Filing Date
2023-06-02
Accepted
2023-06-02 18:57:01
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5483
  Complete submission text file 0001209191-23-034013.txt   6891
Mailing Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121
Business Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121 (858) 422-4300
Prometheus Biosciences, Inc. (Issuer) CIK: 0001718852 (see all company filings)

EIN.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5505 ENDEAVOR LANE MADISON WI 53719
Business Address
Stenhouse Mark (Reporting) CIK: 0001734751 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40187 | Film No.: 23990720